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ABSTRACT Oriented circular dichroism (OCD) was used to characterize and compare in a quantitative manner the secondary
structure and concentration dependent realignment of the antimicrobial peptidesPGLaandMSI-103, and of the structurally related
cell-penetrating peptideMAP in aligned phospholipid bilayers. All these peptides adopt an amphiphilica-helical conformation, and
from solid-state NMR analysis they are known to bind to membranes in two distinct orientations depending on their concentration.
At low peptide/lipid (P/L) ratio the helices are aligned parallel tomembrane surface (S-state), but with increasing concentration they
realign to a tilted orientation (T-state), getting immersed into the membrane with an oblique angle supposedly as a result of dimer-
formation. In macroscopically aligned liquid crystalline 1,2-dimyristoyl-sn-glycero-3-phosphatidylcholine bilayers the two limiting
states are represented by distinct OCDspectra, and all spectra at intermediate peptide concentrations can be described by a linear
combination of these two line shapes. The corresponding fraction of molecules occupying the T-state was determined by ﬁtting the
intermediate spectra with a superposition of the two extreme line shapes. By plotting this fraction versus 1/(P/L), the threshold P/L*
ratio for realignment was extracted for each of the three related peptides. Despite their structural similarity distinctly different
thresholds were obtained, namely for MSI-103 realignment starts already at a low P/L of ;1:236, for a MAP derivative (using a
nonaggregating analog containing a D-amino acid) the transition begins at P/L ;1:156, whereas PGLa needs the highest
concentration to ﬂip into T-state at P/L;1:85. Analysis of the original MAP sequence (containing only L-amino acids) gave OCD
spectra compatible with b-pleated conformation, suggesting that this peptide starts to aggregate with increasing concentration,
unlike theother helical peptides. All these changes in peptide conformation andmembranealignment observedhere byOCDseem
to be functionally relevant, as they can be correlated with the membrane perturbing activities of the three antimicrobial and cell-
penetrating sequences.
INTRODUCTION
Membrane-active antimicrobial peptides with typically 12–
50 amino acids are found in many organisms as part of the
innate immune system to defend the host against invading
bacteria and other microorganisms (1–3). There is wide evi-
dence that pore formation and disruption of the bacterial cell
membrane is one of the prevailing modes of action of these
peptides, although some of them can traverse the membrane
and induce killing by acting on one or more intracellular
targets, or by immunostimulation (4–6). These peptides are
typically cationic, and many representatives adopt an am-
phipathica-helical structurewhen bound to lipid bilayers. It is
well known that bacterial membranes contain negatively
charged lipids on the outer leaﬂet, whereas the corresponding
lipids of eukaryotic cells are predominantly neutral. Electro-
static attraction and hydrophobic peptide-lipid interactions
are thus critical factors that determine the selectivity and po-
tency of these antimicrobial agents. A correlation of primary
sequence or physical properties with biological activity,
however, is rather difﬁcult, because there are no straight
forward parameters that can be used to predict the efﬁciency
of a peptide as a therapeutic agent, nor to assess any delete-
rious side effects on eukaryotic cells.
To examine the structures ofmembrane-active peptides and
to deduce their modes of action, solid-state NMR analysis of
macroscopically oriented membranes is a powerful approach.
A comprehensive picture of membrane-bound peptides in
terms of their molecular conformation and membrane align-
ment was gained at quasi-atomic level by collecting a number
of orientational constraints (7–9). For each constraint, a spe-
ciﬁc NMR-label has to be placed into a suitable position of
the peptide, e.g., 15N- and 13C-isotopes are used in the peptide
backbone, and 2H- and 19F-labels in the amino acid side
chains.Drawbacks of this approach are i), the intrinsically low
sensitivity of NMR that necessitates relatively large amounts
of material (0.1–10 mg peptide per sample), and ii), the need
for synthesizing multiple peptide analogs with selective iso-
tope labels at different positions of the molecule. Thus, a high
expenditure of preparative work, spectrometer time, and costs
for isotope labeled amino acids is necessary to analyze
membrane-bound peptides by solid-state NMR. In view of
these experimental challenges, it is difﬁcult to precisely fol-
low, for example, concentration dependent changes in peptide
structure or membrane alignment.
Optical techniques such as oriented circular dichroism
(OCD) (10–12) and polarized attenuated total internal
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reﬂection FT-IR spectroscopy (13–16), on the other hand, are
convenient alternative methods for monitoring the confor-
mation aswell as the orientation of peptides embedded in lipid
bilayers that are macroscopically aligned with respect to the
light beam. Although both, OCD and FT-IR do not give
atomic resolution, they may be regarded as complementary
methods to solid-state NMR, as they are carried out under
virtually the same conditions (oriented samples) and describe
global features of the secondary structure and alignment of
peptides in lipid membranes. Another major advantage of
both techniques, compared with solid-state NMR, is the
higher sensitivity (e.g., in OCD a 20- to 200-fold lower
amount of peptide, i.e., typically between 0.005 and 0.05 mg
of peptide are used to prepare a sample) (17), and the fact that
for both techniques no isotope labeling is required. Addi-
tionally, OCD and FT-IR allow relative fast spectral acqui-
sition times and exact control of the temperature and
hydration level of the sample. Although FT-IR can be used to
observe both the peptides and the lipid molecules, OCD is
unable to monitor any changes in the bilayer itself. Yet, many
different types of conformational characteristics and changes
thereof can be directly monitored with OCD and shed light on
themechanisms of action of small peptides in lipid ensembles.
OCD structure analysis of a-helical peptides is based on
Mofﬁt’s theory (18), which predicts that the transition dipole
moment of the p-p* electronic transitions of the amide
chromophores in a helix are polarized parallel or perpen-
dicular to the helix axis. The OCD spectrum of a helical
peptide bound to a macroscopically aligned lipid bilayer has a
speciﬁc line shape, which shows its orientation with respect
to the plane of the membrane, as the intensity of the corre-
sponding CD bands depends on this orientation. Character-
istic OCD spectra are obtained for peptides that are either
aligned parallel to the membrane surface or inserted upright
into the lipid bilayer. The distinguishing feature in the OCD
spectra is the presence or absence of a negative band around
208 nm, being indicative of a surface or transmembrane helix
alignment, respectively.
The two distinct types of OCD line shape have been shown
in previous studies on the a-helical antimicrobial peptides
alamethicin (17,19–23), melittin (23–25), and magainin
(25,26). Their spectra were also found to interconvert on
changing the peptide concentration (expressed as the molar
peptide/lipid ratio P/L), suggesting that the peptides are able
to change their alignment in the membrane. Typically, at low
P/L the OCD spectrum corresponds to a helix orientation
parallel to the membrane surface, i.e., the so-called S-state.
Above a certain threshold concentration P/L*, whose value
depends on the lipid composition of the bilayer, the OCD
spectrum gradually changes to one that corresponds to a helix
orientation that is perpendicular to the plane of the bilayer
and has been named the inserted I-state. Any intermediate
states can be ﬁtted by a linear combination of the S- and
I-state spectra, though it is not possible to distinguish be-
tween a fast time-average and a co-existence of two popu-
lations. Besides peptide concentration and lipid composition,
also the level of hydration can inﬂuence the helix alignment
in the membrane, as it was shown for an alamethicin/DPhPC
sample with constant P/L ratio, where the OCD line shape
changed reversibly and continuously from one distinct spec-
trum to another (17,21).
Thus, OCD is a useful technique to differentiate between
distinct alignments of a-helical peptides in lipid bilayers.
Even though oriented CD spectra of b-sheet structures have
been sparsely discussed in the literature (27) and there exists
no proper theoretical basis for interpreting OCD spectra of
any other secondary structure elements yet (28), the OCD
method has been applied in an empirical and comparative
approach to peptides comprising of b-strands (25,29,30).
Analogously to a-helical peptides, it was found that the an-
timicrobial 18-residue protegrin-1 (that has a b-hairpin
structure), and rhesus theta defensin (an 18-residue peptide
with a cyclic structure that is cross-linked by 3 disulﬁde
bonds), also exhibited two extreme OCD spectra that corre-
spond to two distinct alignment states in the lipid bilayer.
Again, the orientational preference is strongly inﬂuenced by
the lipid composition, peptide concentration and hydration
conditions, and intermediate states can be ﬁtted by linear
superpositions of the two extreme spectra (29,30).
Due to these beneﬁts of the OCD technique, and based on
the pioneering work of Olah and Huang (10) and later Wu
et al. (11), we have built an OCD cell to measure oriented
membrane-active peptides and proteins in their native lipid
environment. The cell can be easily implemented into the
sample compartment of a commercially available CD spec-
tropolarimeter. With this OCD method at hand, it is now
possible to speed up the process of screening many different
experimental conditions, such as P/L ratio, temperature, and
humidity of the sample, under which interesting and func-
tionally relevant orientational and secondary structural
changes are expected to occur in peptide-lipid systems. After
identifying the key conditions by OCD, these parameters can
then be speciﬁcally adjusted in designated samples, to re-
solve the structural details by the more elaborate methods like
solid-state NMR, electron spin resonance, x-ray diffraction,
or atomic force microscopy.
As an example for taking advantage of the OCD technique,
we have studied the secondary structure and orientation
of three a-helical peptides in a model membrane. The 21-
residue peptide PGLa (GMASKAGAIAGKIAKVALKAL-
NH2), which belongs to the magainin family (31), is one of
many antimicrobial peptides found in the skin of the African
frog Xenopus laevis (32–34). MSI-103 ([KIAGKIA]3-NH2)
is a product of rational drug design based on the sequence of
PGLa as a template, with an improved antimicrobial activity
(35,36). The ‘‘Model Amphipathic Peptide’’ MAP (KLAL-
KLALKALKAALKLA-NH2) is also an artiﬁcial sequence,
but designed to exhibit cell-penetrating properties (37). All
three peptides are cationic, with a net charge of15 to17, and
the amino acid sequence implies an amphiphilic a-helical
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structure with the charged lysine side chains on one side and
hydrophobic residues on the opposite face. They all have a
disordered structure in aqueous solution and form a-helices
in contact with charged lipid membranes (34,36,38). The
conformation, alignment, and dynamics of PGLa (39–42),
MSI-103 (43), and MAP (44) in oriented lipid bilayers have
been comprehensively characterized using solid-state NMR.
Each peptide has been found to realign in the membrane from
an S- to a T-state with increasing concentration, but the in-
dividual threshold P/L* ratios were not accessible and could
not yet be compared in a quantitative manner nor correlated
with the respective biological activities.
In this study we present OCD data of the three different
peptides in oriented 1,2-dimyristoyl-sn-glycero-3-phospha-
tidylcholine (DMPC) bilayers, verifying that they all acquire
an a-helical structure in membrane-bound conditions. Ad-
ditionally, systematic OCD measurements at different P/L
ratios could show the realignment of these peptides from an
S- to a T-state, as found in our earlier solid-state NMR
studies. From spectral deconvolution of the intermediate line
shapes, the precise threshold concentration at which re-
alignment starts could be extracted for each peptide. More-
over, when studying the original MAP sequence as well as
two analogs carrying a D- and L-enantiomeric CF3-Phg side
chain, we were able to compare their respective helicities and
reorientations. At low P/L the OCD spectra of the MAP wild-
type and of the L-epimer analog showed an a-helical struc-
ture, whereas at high peptide concentration they turned into a
b-stranded type. Thus, the stiff D-CF3-Phg side chain evi-
dently prevents peptide aggregation, and has been used
successfully to convert the original MAP sequence into an
improved membrane-perturbing agent that does not aggre-
gate but realigns in the lipid bilayer just like the related
peptides PGLa and MSI-103.
METHODS
Materials
DMPC was purchased from Avanti Polar Lipids (Alabaster, AL) and used
without further puriﬁcation. PGLa (GMASKAGAIAGKIAKVALKAL-
NH2), MSI-103 ([KIAGKIA]3-NH2), and MAP (KLALKLALKALKAAL-
KLA-NH2) peptides were synthesized on an Applied Biosystems 433A
synthesizer (Foster City, CA), using standard solid-phase Fmoc-protocols
(45). The crude material was puriﬁed by RP-HPLC on a C18 column (103
200 or 22 3 250 mm, GRACE) using an acetonitrile/water gradient sup-
plemented with 5 mM HCl (46). Epimeric peptides of the MAP analog
(KLALKLALKALKAA-4-CF3-Phg-KLA-NH2) were obtained by replacing
Leu15 by 4-CF3-D,L-phenylglycine (CF3-Phg) followed by their HPLC sep-
aration. The conﬁgurational analysis of the D- and L-epimers was carried out
usingMarfey’s derivatization as described previously (46). The identity of all
peptides was conﬁrmed by MALDI-TOF/ESI mass spectrometry, and purity
(;95%) by analytical RP HPLC (4.6 3 250 mm).
Oriented samples
Oriented peptide-lipid samples for OCD measurements were prepared ac-
cording to the single substrate method described by Ludtke et al. (47). An
appropriate peptide-lipid solution was deposited onto a circular quartz glass
plate with 20-mm diameter (Suprasil QS, Hellma Optik, Jena, Germany),
which served as a UV-transparent window in the OCD cell. Before use, the
quartz glass window was cleaned in concentrated nitric acid, and rinsed
thoroughly and repeatedly with distilled water and ﬁnally with ethanol.
Afterward, the window was dried in an oven at ;60C.
Stock solutions with a lipid concentration of 25 mg/mL were prepared by
dissolving a total amount of ;5 mg of lipid in a 1:1 (v/v) mixture of chlo-
roform and methanol. Similarly, peptide stock solutions with concentrations
of 0.1–1.0 mg/mL were made by dissolving the lyophilized peptide in an
identical solvent mixture. Next, lipid and peptide solution aliquots were
mixed in a vial to obtain the desired P/L molar ratio and thoroughly vortexed.
A volume of 15–80 ml (depending on P/L ratio) of the dissolved mixture was
deposited onto the OCD quartz glass window using a gas tight syringe, and
the solvent was allowed to evaporate until the sample appeared dry. After-
ward it was placed in a desiccator under 2-mbar vacuum for at least 3 h to
ensure a complete removal of organic solvent. Finally, the window with the
dried sample was assembled into the OCD cell and hydrated for ;15 h at
30C and 97.0% relative humidity (rH) or at 40C and 96.4% rH (obtained by
using a saturated K2SO4 solution; see description of the OCD cell), on which
the lipid spontaneously aligns into well-oriented bilayers. The diameter of the
membrane-covered sample area was between 9 and 12 mm. The amount of
lipid and peptide deposited on the quartz glass plate was kept below 0.2 mg
and 30 mg, respectively, resulting in comparatively thin samples to avoid
absorption ﬂattening and linear dichroism artifacts (48).
OCD cell
The home-built set-up used for the OCD measurements is similar to the cell
described by Chen et al. (17). The optical path of the CD spectropolarimeter
is parallel to the cylindrical axis of the cell and normal to the quartz glass
window with the oriented sample. A cross-sectional view of the OCD cell is
shown in Fig. 1. It consists of an aluminum frame with two ring-shaped
cavities and a central bore for taking up the sample holder. Water from a
computer-controlled external water bath thermostat (Julabo) with a thermo-
electric feedback module was passed through the closed outer cavity of the
cell, which allowed to control the temperature of the whole cell over a
FIGURE 1 Cross-sectional view of the home-built OCD cell, developed
to measure peptide alignment in lipid bilayers at constant temperature and
humidity. Two circular reservoirs contain the thermostated water and the salt
solution used to adjust the relative humidity in the central sample chamber.
The cell is mounted on a rotation stage in the sample compartment of the CD
spectropolarimeter and can be rotated around the cylindrical axis, which is
coincident with the optical path of the polarized light.
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5–50C range with a stability of 60.1C. The second cavity around the
central bore was ﬁlled with a small volume (;300–500 ml) of saturated salt
solution for controlling the humidity of the sample. The sample holder
consists of a threaded tube with two quartz glass windows ﬁxed vertically
inside at a distance of 6 mm by two brass rings. Halfway between the win-
dows the casing contains holes in a circular arrangement around the tube, so
that the vapor from the salt solution can hydrate the sample without direct
contact between the solution and the sample. The space between the two
windows is sealed by four O-rings to avoid contact with ambient air. The
humidity and temperature within the sample cell is monitored by a capacitive
relative humidity and temperature sensor (SHT 75, Sensirion, Zurich,
Switzerland), which is ﬁxed in the immediate vicinity of the sample (within
12 mm) in a gap between the sample holder and the cavity containing the salt
solution. The humidity can be measured with an absolute accuracy of61.8%
rH by the sensor (63% at values.90% rH). When using a saturated K2SO4
salt solution with 96–98% rH, the equilibration of temperature and humidity
in the closed OCD cell takes ;2–3 h. However, to assure proper hydration
across the whole depth of the lipid bilayers, all samples were hydrated
overnight (;15 h). Sample equilibration was ensured by acquiring OCD
spectra over a period of hours, until they did not change any further when
taken for instance within 3–4 h.
The cylindrical OCD cell was mounted in the sample compartment of the
spectropolarimeter on a rotation stage with a computer-controlled stepping
motor (SKIDS-60YAW (uz); SigmaKoki Ltd., Tokyo, Japan). The OCD cell
mount was attached in such a manner that the optical axis of the spectro-
polarimeter light beam coincides with the cylindrical axis of the cell and a
symmetrical rotation around the beam axis was assured. Such rotational
averaging diminishes possible spectral artifacts due to the linear dichroism
(LD) that could be caused by imperfections in the sample, strain in the quartz
glass plates, or imperfect alignment of the windows (12,17). To ensure that
such artifacts are minimal, an LD spectrum of the sample was acquired after
each series of OCD measurements. If the maximum LD was #0.003 dOD,
the corresponding rotationally averaged OCD spectra were rated to be free of
LD artifacts.
Oriented circular dichroism spectroscopy
CD measurements were carried out on a Jasco J-810 spectropolarimeter
(Jasco, Tokyo, Japan). The instrument was calibrated with a 0.06% (w/v)
aqueous solution of ammonium (1)-10-camphorsulfonate (ACS) at 290.5
nm. OCD spectra were acquired between 260 and 180 nm at 0.1-nm inter-
vals. Three repeat scans at a scan rate of 10 nm min1, 4 s response time and
1 nm bandwidth were averaged for each sample at every 45.0 of rotation of
the cell, as described in Chen et al. (17) resulting in spectral acquisition times
of;3 h per sample. The eight successive spectra were averaged. Background
spectra of pure lipid bilayers were measured likewise in a separate experi-
ment as a control, and were subtracted from the corresponding spectra of the
peptide-containing samples.
OCD spectral analysis
A method for ﬁnding two extreme spectra that correlate with different
alignments of an a-helix in lipid bilayers, e.g. in the S- and I-state, has been
described in the literature for different peptides in various lipid environments
(17,19,26,30). It was shown that intermediate OCD spectra can be described
as a linear superposition of the two extreme spectra. If one can ﬁnd these
extreme spectra by varying the temperature or humidity of a single sample,
then the amplitudes of the spectra will be intrinsically normalized to one
another. However, for the peptides investigated in this study, the extreme
spectra were identiﬁed by varying the P/L ratio, hence many different sam-
ples had to be prepared and the resulting OCD spectra had to be normalized
according to the different peptide concentrations. In such cases one common
point of intersection of the two extreme spectra and of all intermediate
spectra, i.e., an isodichroic point, must exist (17). In our experiments, this
isodichroic point was located in the following way: the relative amounts of
peptide in the different OCD samples were known from the preparation
protocol (as quantitatively conﬁrmed by their UV spectra obtained during the
measurements). To normalize the OCD spectra, in a ﬁrst step each original
spectrum was multiplied by an individual factor that was calculated from the
ratio of the amount of peptide in the least concentrated sample and the
amount of peptide in the respective sample. The resulting scaled spectra will
intersect one another not exactly in one point but close to one point (given
that there are always some small errors in peptide concentration, e.g., due to
slightly different sample areas). This procedure was only used to locate the
approximate position of the isodichroic point with an accuracy of;62 nm.
In the second round of the normalization procedure, each original OCD
spectrum in any one peptide/lipid system was multiplied once again by a
certain factor, which was now calculated from the ratio of the ellipticity of the
least concentrated sample and the ellipticity of each respective sample at a
single selected wavelength near the approximate position of the isodichroic
point. This procedure was repeated at four or ﬁve different wavelengths close
to the expected isodichroic point, resulting in a set of normalized OCD
spectra intersecting in one point for each selected wavelength. Afterward, for
each set the intermediate spectra were ﬁtted by a linear combination of the
extreme spectra (representing S- and T-state). Finally, the standard devia-
tions of experimental and ﬁtted data of each intermediate spectrum for a
particular set were compared with the standard deviations obtained for the
sets at other wavelengths. The set of normalized spectra with the lowest
average standard deviation of all intermediate spectra was considered best,
and in this way the exact location of the isodichroic point of a peptide/lipid
system was identiﬁed.
RESULTS AND DISCUSSION
OCD spectra of PGLa, MSI-103, and MAP in
DMPC bilayers
From solution CD experiments described in the literature it is
known that PGLa, MSI-103, and MAP change from a ran-
dom coil conformation in aqueous solution to an a-helical
structure in the presence of lipid vesicles (34,36,38). Solid-
state NMR studies have shown that interaction of these
peptides with hydrated lipid bilayers not only induces an
a-helical fold, but also a realignment of the helix, from an
orientation parallel to the membrane surface (S-state) at low
peptide concentration to a tilted orientation (T-state) at high
concentration (39–44). As there was no OCD data available
for these peptides to date, we have prepared, analogously to
the earlier NMR experiments, oriented DMPC membranes
with the peptides embedded at various P/L ratios, to i), study
their conformation and alignment with an independent
technique, ii), to ﬁnd out whether the OCD method conﬁrms
the previous solid-state NMR results, and iii), to determine
quantitatively the individual thresholds of realignment for the
three peptides for the ﬁrst time, which might then iv), be
compared and correlated with their respective membrane-
perturbing effects.
Fig. 2 A shows the normalized OCD spectra of the natu-
rally occurring peptide PGLa in oriented DMPC bilayers in
the liquid-crystalline (La) phase (40C) for different P/L ra-
tios (all at full hydration). The line shape of these OCD
spectra, with a positive maximum around 192 nm and two
negative bands at 209 and 223 nm, is characteristic of a
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peptide with a signiﬁcant a-helical content. If one compares
the spectra of PGLa at P/L¼ 1:164 and 1:109 with the S-state
spectrum of the a-helical antimicrobial peptide alamethicin
in the literature (17,22), the fully pronounced negative CD
band at 209 nm is indicative of the S-state for PGLa at low
peptide concentrations. With increasing PGLa concentration
the spectral amplitude generally decreases at all wavelengths,
but also the relative intensity of the 209 nm band compared to
the 223 nm band is diminished, and simultaneously the
maximum of the positive band is shifted from 192 to 195 nm,
until at a P/L ratio of ;1:20 a ﬁnal state is obtained. These
spectral changes clearly reﬂect the realignment of the peptide
helix as a function of concentration, similar to the OCD
changes of other antimicrobial peptides described in the lit-
erature, e.g., for alamethicin and melittin (17). However, in
contrast to those peptides, for PGLa the extreme spectrum at
high P/L ratio still has a pronounced residual negative in-
tensity, and the band at 209 nm does not disappear com-
pletely. This observation suggests that a fully immersed I-state
is not reached under the experimental conditions chosen here.
Instead, realignment of PGLa stops at a tilted T-state, where
the helix is oriented at an oblique angle with respect to the
membrane surface. These ﬁndings are in full agreement with
the solid-state NMR results on PGLa in DMPC (41), which
showed that at a P/L of 1:200 the peptide lies almost ﬂat on
the bilayer surface with a tilt angle t of 98 (S-state), whereas
at a high concentration of P/L ¼ 1:50 the tilt angle increases
by ;30 to t ;125 (T-state). It has to be mentioned that
OCD does not allow to discriminate between the following
three possibilities: i), whether the T-state is a genuine state
with a stable alignment, ii), whether the T-state lineshape is
an arithmetically weighted sum of the more extreme I- and
S-state spectra, or iii), whether it is a time-averaged inter-
mediate between rapidly interconverting S- and I-states.
Nevertheless, we have observed previously by 2H-NMR a
dynamic interconversion between the S- and T-states on a ms
timescale (42). The rate of exchange was obtained from the
quadrupolar splittings, which were averaged by motions on
the timescale of 20 ms, thus showing that solid-state NMR is
able to detect such averaging. Yet, a recent 19F-NMR anal-
ysis proved clearly that the T-state is a genuine and stable
orientational state (49), rather than an average between the
S- and I-states, because the 19F dipolar splittings showed
plateau regions for the T-state that do not correspond to
arithmetic averages. Hence we suggest that this OCD spec-
trum represents a genuine T-state population.
A comparable realignment has been observed by NMR for
the related, designer-made antimicrobial peptide MSI-103 in
DMPC bilayers (in the La phase at full hydration). Fig. 2 B
shows the normalized OCD spectra of MSI-103 for varying
P/L ratios, exhibiting also the characteristics of a peptide with
an a-helical conformation. The spectra show that MSI-103
undergoes the same kind of S- to T-state transition as PGLa,
given the distinct intensity decrease of the negative 207 nm
band, the red-shift of the positive peak near 191 nm, and the
overall reduction in amplitude. The spectra at a P/L ratio of
1:400 and 1:300 are almost equivalent and correspond to the
S-state, whereas at 1:200 the line shape starts to change.
These P/L values indicate that the MSI-103 begins to realign
from the S- to the T-state at much lower concentration than
PGLa. Following the gradual changes by way of a series of
intermediate spectra, the ﬁnal T-state is reached at P/L ratios
of 1:40 and 1:20. Again, the 207-nm band does not disappear
completely, which conﬁrms that the peptide is not in the
I-state. These results obtained from OCD are again consistent
with our previous 19F-NMR structure analysis of MSI-103 in
oriented DMPC bilayers, which showed an S-state at P/L ¼
1:400 with a tilt angle of t¼ 101 (43). For a sample of P/L¼
1:200, 2H-NMR had shown an increased tilt angle of 111,
representing a mixture of pure S- and T-state, whereas at 1:50
the pure T-state was reported with a tilt angle of 125 (43),
similarly to the OCD results presented.
FIGURE 2 Oriented CD spectra of peptides in DMPC bilayers, showing
their predominant a-helical conformation and showing their realignment
from a surface-bound S- to a tilted T-state induced by increasing the molar
P/L. (A) PGLa: all spectra were acquired at 40C and 98% rH, and normalized
to cross the same isodichroic point at 199 nm (see Methods). (B) MSI-103
(modiﬁed from Strandberg et al. (43)): same conditions, spectra were nor-
malized to an isodichroic point at 198 nm.
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A completely different behavior is observed in Fig. 3 A in
the OCD measurements of the MAP wild-type peptide in
DMPC bilayers. Here, it was difﬁcult to obtain OCD spectra
in the ﬁrst place, because the lipid-peptide preparations ten-
ded to slide off the vertical window in the OCD cell during
the measurement at 40C (i.e., the temperature chosen above
the DMPC phase transition). In only two cases did we
manage to get stable samples, and these two OCD spectra,
depicted in Fig. 3 A for P/L ratios of 1:100 and 1:15, show
clearly a conformational change on going from low to high
peptide concentration. The spectrum at P/L ¼ 1:100 shows a
predominantly a-helical conformation with an S-state
alignment (Fig. 2, A and B). At P/L¼ 1:15, on the other hand,
the OCD spectrum exhibits a broad positive band with a
shoulder at ;189 and a maximum at 200 nm, and a single
negative band around 217 nm, which points to a more
b-stranded fold. To better understand this phenomenon and
to emphasize the potential of the OCD technique in sup-
porting solid-state NMR structural investigations with la-
beled peptides, we carried out further OCD measurements
with twomodiﬁedMAP analogs. In KLALKLALKALKAA-
CF3-Phg-KLA-CONH2, the leucine residue at position 15
had been substituted by 4-CF3-D,L-phenylglycine, resulting
in two epimeric peptide analogs containing D-CF3-Phg and
L-CF3-Phg. As already mentioned above, OCD does not
require any isotope labeling, but of course it allows mea-
suring such peptides, which had originally been synthesized
for the solid-state 19F-NMR analysis. A comparison of con-
ventional CD spectra of the wild-type (WT) and CF3-Phg
labeled MAP analogs in TFE/phosphate buffer (1:1 v/v)
proved that a single substitution with the nonnatural 19F-la-
beled amino acid did not induce any signiﬁcant conforma-
tional changes of the peptide in solution (44).
Fig. 3 B shows the normalized OCD spectra of the D-epi-
meric MAP analog in DMPC membranes for varying P/L
ratios, using same conditions as in the experiments described
above. In this case no ﬂuidization of the samples was ob-
served. As it had been expected for the amphiphilic MAP
sequence, the line shape at low peptide concentration (P/L
;1:220) now exhibits the typical features of an a-helix, with
a positive band around 190 nm and the two negative peaks at
207 and 223 nm. The helicity of the MAP D-epimer seems to
be somewhat lower than for the other peptides PGLa, MSI-
103, and the MAP-WT. This is deduced from the smaller
intensity ratio between the positive maximum at 190 nm and
the negative minimum at 207 nm in relation to the other
peptides, which implies a higher random coil contribution in
the MAP D-epimer, diminishing the intensity of the positive
band in the spectral range from 190 to 205 nm. The fully
pronounced 207 nm band in the OCD spectrum of the MAP
D-epimer at P/L ;1:220 shows once again that also this
peptide lies parallel to the membrane surface at low con-
centration. With increasing P/L ratio the intensity of the band
at 207 nm decreases compared to 223 nm, showing that the
D-epimer undergoes a realignment as an a-helix in the same
FIGURE 3 OCD comparison of the cell-penetrating MAP wild-type pep-
tide and its CF3-Phg substituted D- and L-epimeric analogs in DMPC bilayers
as a function of P/L ratio. All spectra were acquired at 40C and 98% rH, and
normalized to cross the same isodichroic point at 197.5 nm. (A) MAP wild-
type: showing at a low P/L ratio of 1:100 the peptide in an a-helical
conformation andS-state,whereas at highP/Lof 1:15 ab-stranded structure is
predominant. (B) MAP D-epimer: showing an a-helical conformation
throughout, and realignment from S- to T-state with increasing peptide
concentration. (C) MAP L-epimer: showing the peptide in an a-helical
conformation and S-state at low concentration, and b-pleated structure at
high P/L ratios.
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way as PGLa and MSI-103, but in contrast to MAP-WT. For
the D-epimeric MAP analog the extreme spectrum at high
peptide concentration is reached at P/L ratios between 1:44
and 1:17. The residual negative ellipticity at 207 nm shows
once again that this peptide favors a tilted state over an in-
serted state in liquid crystalline DMPC. Similar results had
been recently obtained by solid-state 19F-NMR (44), where
the same MAP D-epimer had exhibited two distinct states,
and was found to be mobile (rather than immobilized by
aggregation or multimerization) up to a high P/L of 1:20.
The OCD line shapes of the MAP L-epimer showed a
behavior similar to that of MAP-WT. The spectra depicted in
Fig. 3 C were normalized to intersect at the isodichroic point
of the D-epimer at 197.5 nm, to allow for a better comparison
with the data in Fig. 3, A and B. The corresponding spectra in
Fig. 3 C clearly prove that at a low P/L ;1:220 this peptide
has the propensity to form an a-helix and adopt an S-state
parallel to the membrane surface. However, when the con-
centration is raised the line shape changes drastically, as for
MAP-WT. The spectrum at P/L of 1:110 compared with the
spectrum at 1:220 shows a much broader positive band with a
maximum at;191 nm, and only a single broad negative band
around 217 nm. For a pure b-stranded structure one would
expect the maximum of the positive band at;197 nm, hence
this spectrum seems to represent a mixture of a large fraction
of b-stranded and a lower percentage of a-helical confor-
mations. For higher P/L ratios a shoulder around 190 and a
maximum at ;202 nm appears and again the distinct nega-
tive band at 217 nm, in full accordance with wild-type MAP
(Fig. 3 A).
Only few OCD studies of peptides with a predominant
b-pleated structure have been reported: the spectra of the
synthetic polypeptide poly(Leu-Lys) (28), the cyclic peptide
RTD-1 (30), and of protegrin-1 (29). Some of these spectra
were correlated with a b-strand conformation oriented par-
allel to the membrane surface. Generally, the MAP L-epimer
andMAP-WT spectra with P/L. 1:110 presented here, have
a line shape similar to the S-state spectra of RTD-1 and
poly(Leu-Lys), e.g., a broad maximum around 195 nm and
one pronounced minimum at wavelengths .212 nm, how-
ever the exact position of the bands does not agree. In contrast
to the RTD-1 and poly(Leu-Lys) data, the MAP spectra at
high P/L ratios also possess strong positive ellipticity at
wavelengths .200 nm, with an intersection of the zero
baseline between 208 and 212 nm. Additionally, a similarity
with solution CD spectra of Ab-(1–42) peptide in its aggre-
gated form (50) can be stated, which also shows a rather
broad maximum with positive ellipticity in the range of 190–
205 nm and a broad minimum between 212–220 nm. Due to
these similarities with CD and OCD spectra of b-sheet pep-
tides one can safely assume a predominantly b-pleated
structure for the MAP wild-type and its L-epimeric analog at
high P/L ratios in DMPC bilayers. Solid-state 19F-NMR
studies have also reﬂected an immobilization of MAP at high
concentration, suggesting its extensive aggregation (44).
Additionally, IRRAS investigations on MAP conﬁrm the
transition from helical to b-pleated conformation at high
concentrations (51). The absence of any typical b-pleated
features in the OCD spectra of the D-epimeric MAP analog
(Fig. 3 B) can be explained by the fact that the stiff D-CF3-
phenylglycine side chain projects away from the peptide
backbone in a sterically obstructive manner that hampers
self-assembly of the peptides into b-sheets, as discussed
in Reichert et al. (52). The incorporation of this unnatural
D-amino acid has thus proven to be an effective trick to prevent
the formation of b-stranded ﬁbrils or cross-b-sheet amyloid.
Threshold values for the transition between
S- and T-state
From the OCD spectra of PGLa, MSI-103, and MAP pre-
sented in Fig. 2, A and B, and Fig. 3 B, the threshold con-
centrations for the transition from S- to T-state were
determined according to the method described in Chen et al.
(17). The respective fractions of the T- and S-states were
determined by deconvolution of the intermediate spectra,
using the corresponding extreme spectra. The calculated
fraction f of the T-state was plotted as a function of the re-
ciprocal P/L ratio, as described in Chen et al. (17). This re-
sulted in characteristic curves for all three peptides (Fig. 4).
At low concentration all peptides are in the S-state (f  0),
until the T-state starts to appear at a threshold concentration
P/L*, and beyond some higher threshold P/L# all peptides
have ﬁnally reached the full T-state. For each of the three
peptides, the data points in the transition region between the
FIGURE 4 Fraction f of the tilted peptide in the T-state as a function of
the inverse (P/L) ratio for PGLa, MSI-103, and the MAPD-epimer in DMPC
bilayers. Data in the transition regions were ﬁtted to straight lines, whose
points of intersection with the f ¼ 0 line give the threshold P/L* values,
where the T-state starts to appear. Above some higher threshold value P/L#,
which is obtained from the intersection of the ﬁtted lines with theF¼ 1 line,
all peptides have ﬁnally reached the T-state.
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two thresholds concentrations fall on a straight line. The in-
dividual threshold concentrations P/L* for PGLa, MSI-103
and MAP were assessed from the intersection of the corre-
sponding lines of best ﬁt with the line of f ¼ 0, and the P/L#
values were obtained from the intersection with the linef¼ 1.
For all of the three peptides P/L# was ;4 times P/L*, but
remarkably the actual value of P/L* is very different for each
peptide. MSI-103 starts already to realign into the T-state at
a low P/L* of ;1:236, whereas for MAP, transition starts at
P/L* ;1:156, and PGLa needs the highest concentration to
get into T-state at P/L* ;1:85. (In solid-state NMR experi-
ments described in Tremouilhac et al. (42), the threshold
concentration P/L* for PGLa realignment in DMPC was
estimated to be between 1:200 and 1:100, which indicates a
small discrepancy to the value of 1:85 determined here by
OCD. However, this can be explained by somewhat different
temperature and humidity conditions of the twomeasurement
series.) The conclusion that MSI-103 has a much lower
threshold than PGLa for realignment from the S- to the
T-state, had also been observed in a qualitative manner by
solid-state NMR (43).
Table 1 lists the threshold concentration (given as P/L*),
the net charge, and the hydrophobic dipole moment (mH) per
residue of the three peptides PGLa, MSI-103, and D-epimeric
MAP, when folded as an a-helix. The magnitude of mH is a
measure of the amphiphilicity of the helix (53,54). Amphi-
philic a-helical peptides, such as the ones investigated here,
having mainly polar side chains protruding from one face and
apolar ones protruding from the other, are characterized by
large values of mH, and they tend to seek interfaces between
polar and apolar phases, such as the surfaces of membranes.
Hydrophobic moments were calculated according to Eq. 1 of
Eisenberg et al. (53), using four different hydrophobicity
scales, namely the Eisenberg normalized consensus scale
(54), and three whole-residue hydrophobicity scales by
White et al. (55,56). The decrease of the threshold concen-
tration P/L* in the order PGLa . MAP . MSI-103 is cor-
related inversely with the net charge of the respective
peptides on the one hand, and with the hydrophobic moment
per residue on the other hand, regardless of which hydro-
phobicity scale is used for calculating mH. In other words, the
higher the net charge and the amphiphilicity of a helical
peptide, the lower is its threshold concentration necessary for
realigning from a surface-bound to a tilted state in the DMPC
lipid bilayer. The ﬂip from the S- to the T-state has been
explained by the formation of dimers in our earlier solid-state
NMR investigations of these peptides (39–43), which thus
seems to correlate with the membrane-perturbing activity of
the respective peptide sequence. The lower threshold con-
centration found for MSI-103 in DMPC model membranes
with both independent techniques (solid-state NMR and
OCD) and the increased tendency for dimerization could be a
ﬁrst indication for a correlation with the differential anti-
bacterial activities of these two peptides against seven bac-
terial strains, which has been tested by our group (57).
Indeed, MSI-103 needs a lower minimum concentration to
inhibit bacterial growth than PGLa, as was also found in the
original study of the designer-made peptide sequences, where
MSI-103 turned out to be more effective against bacteria with
four- to eightfold lower MIC than PGLa (35,36). Neverthe-
less, to ascertain such a general correlation the order of the
threshold values should be tested in many more different
types of lipids.
MAP, which has a similar sequence as the two antimi-
crobial peptides a net charge of 16, and a hydrophobic
moment, which lies in between the two other peptides, is
known for its cell-penetrating properties rather than for its
antimicrobial activity. Nevertheless, due to its comparable
amphiphilic structure a concentration increase in the lipid
bilayer also leads to realignment of the peptide showing an
intermediate threshold concentration. This can be understood
from recent ﬁndings that there seem to be common steps in
certain translocation mechanisms of cell-penetrating peptides
and in the lytic action of antimicrobial peptides in lipid
membranes (58).
CONCLUSIONS
Oriented circular dichroism analysis of the three membrane-
active peptides PGLa, MSI-103, and the D-epimer of MAP,
showed that they are all a-helical when embedded in hy-
drated DMPC bilayers in the liquid crystalline state. The
OCD technique, which gives complementary information to
solid-state NMR but requires no labeling, conﬁrms the re-
alignment of these helices from a surface bound S-state to a
tilted T-state with increasing peptide concentration, as re-
ported earlier by NMR. Realignment into the T-state started
to occur in all cases at a well-deﬁned threshold concentration
P/L*, which varies considerably from peptide to peptide
(PGLa . D-epimeric MAP . MSI-103). This threshold
TABLE 1 Comparison of the threshold concentration P/L* for
realignment, the net charge, and the hydrophobic dipole moment
mH (calculated using different hydrophobicity scales) of PGLa,
D-epimeric MAP, and MSI-103
Parameter PGLa MAP MSI-103
Threshold P/L* ratio
for realignment
1:85 1:156 1:236
Net charge 15 16 17
mH/residue (Eisenberg, normalized
consensus scale) (53,54)
0.411 0.524y 0.631
mH/residue (White, octanol
interface scale) (55,56)
0.357 0.377y 0.594
mH/residue (White, interface
scale) (55,56)
0.176 0.212y 0.247
mH/residue (White, octanol
scale) (55,56)
0.519 0.588y 0.833
ymH data for D-epimeric MAP were calculated by using the hydrophobicity
of Leu at position 15 (MAP-WT) because the hydrophobicity value of the
nonnatural, hydrophobic amino acid 4-CF3-phenylglycine is not listed in
the scales used. However, the effect on the actual value of mH should be
marginal.
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seems to correlate with the tendency of the peptides to di-
merize and perturb the lipid bilayer, which may be related to
their respective antimicrobial and cell penetrating functions.
Furthermore, for the wild-type sequence of MAP and an
L-epimeric analog, a distinct conformational change from an
a-helical to a b-stranded conformation was observed, in-
dicative of aggregation. These ﬁndings show the ability of
OCD to identify and characterize functionally relevant con-
centration-dependent changes of membrane-bound peptides
in a quantitative manner.
We are grateful to Silvia Gehrlein, Stefanie Maurer, and Olaf Zwernemann
at Forschungszentrum Karlsruhe for help with peptide synthesis and
puriﬁcation, Heide Mathieu for recording the OCD spectra, and Karl
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